Stockscreener 앱 받기
13.20
3.75%
-0.51
Wave Life Sciences Ltd 주식(WVE)의 최신 뉴스
Wave Life Sciences to present WVE-006 trial data at ATS - Investing.com
Wave Life Sciences announces acceptance of late-breaking oral presentation on Wve-006 for alpha-1 antitrypsin deficiency at the American Thoracic Society international conference - marketscreener.com
Experimental RNA treatment for alpha-1 gets late-breaking lung conference slot - Stock Titan
Q1 EPS Forecast for WAVE Life Sciences Raised by Analyst - MarketBeat
FY2029 Earnings Forecast for WVE Issued By HC Wainwright - MarketBeat
Wave Life Sciences Obesity Proof Of Concept Sparks Focus On Pipeline Upside - simplywall.st
WVE SEC FilingsWave Life Scienc 10-K, 10-Q, 8-K Forms - Stock Titan
Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with 140% Upside Potential - DirectorsTalk Interviews
How Strong Q4 Revenue Amid Deeper Losses At Wave Life Sciences (WVE) Has Changed Its Investment Story - Yahoo Finance
Wave Life Sciences (WVE) Earnings Call Transcript - AOL.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2025 Earnings Call Transcript - Insider Monkey
HC Wainwright Reiterates "Buy" Rating for WAVE Life Sciences (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near - Yahoo Finance
Artisan Partners Limited Partnership Trims Stake in WAVE Life Sciences Ltd. $WVE - MarketBeat
How Mixed Q4 Results, Obesity Data and Cash Runway News At Wave Life Sciences (WVE) Has Changed Its Investment Story - simplywall.st
Wave Life Sciences Ltd. (WVE): A Bull Case Theory - Finviz
Primecap Management Co. CA Has $13.90 Million Position in WAVE Life Sciences Ltd. $WVE - MarketBeat
Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings - Yahoo Finance
Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Insider Sells 33,194 Shares of Stock - MarketBeat
Wave Life Sciences (WVE) officer nets 33,194-share sale after option exercises - Stock Titan
WAVE Life Sciences (NASDAQ:WVE) Shares Down 10.6%What's Next? - MarketBeat
WAVE Life Sciences Q4 Earnings Call Highlights - MarketBeat
Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight - GuruFocus
Wave Life Sciences (WVE) Quarterly Loss Deepens Bear Narratives On Profitability And Cash Burn - simplywall.st
Wave Life Sciences: Q4 Earnings Snapshot - theheraldreview.com
WAVE Life Sciences Ltd (WVE) Q4 2025 Earnings Call Highlights: N - GuruFocus
Wave Life Sciences at Oppenheimer Conference: Strategic Insights on RNA Medicines - Investing.com Australia
Wave Life Sciences (WVE) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Wave Life Sciences Posts Wider FY25 Loss, Highlights Progress Across RNA Pipeline - Nasdaq
Earnings call transcript: Wave Life Sciences Q4 2025 sees revenue drop - Investing.com
Wave Life Sciences (WVE) Reports Strong Q4 Revenue and Advances in Obesity Treatment - GuruFocus
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Investing News Network
WAVE Life Sciences Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Wave Life Sciences: Fourth Quarter Financial Overview - Bitget
Wave Life Sciences Swings to Q4 Net Loss, Revenue Falls - marketscreener.com
Earnings Flash (WVE) Wave Life Sciences Posts Q4 Loss $0.30 a Share, vs. FactSet Est of $0.26 Loss - marketscreener.com
Earnings Flash (WVE) Wave Life Sciences Ltd. Reports Q4 Revenue $17.2M, vs. FactSet Est of $16.1M - marketscreener.com
WAVE LIFE SCIENCES ($WVE) Releases Q4 2025 Earnings - Quiver Quantitative
Wave Life Sciences Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
Wave Life Sciences Ltd earnings missed by $0.03, revenue topped estimates By Investing.com - Investing.com India
Wave Life Sciences Highlights 2025 Results and Obesity Progress - TipRanks
Wave Life Sciences Ltd earnings missed by $0.03, revenue topped estimates - Investing.com
Wave Life Sciences Ltd. SEC 10-K Report - TradingView
Earnings Summary: WAVE Life Sciences Q4 - Benzinga
Wave Life Sciences (NASDAQ: WVE) doubles cash, widens 2025 loss on R&D push - Stock Titan
Earnings Preview: WAVE Life Sciences - Benzinga
Investors brace for Wave Life Sciences earnings on obesity bets By Investing.com - Investing.com Canada
Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring 147% Upside In Biotech Innovation - DirectorsTalk Interviews
WAVE Life Sciences (WVE) Projected to Post Earnings on Tuesday - MarketBeat
A Look At Wave Life Sciences (WVE) Valuation After WVE-006 Rights Return And Obesity Program Spotlight - simplywall.st
Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference - The Manila Times
Wave Life Sciences (WVE) Valuation Check After Regaining WVE-006 Rights And New Buy Analyst Coverage - Yahoo Finance
Is Haverty Furniture Companies Inc stock a buy or sell2025 Year in Review & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Merger Talk: Is Wave Life Sciences Ltd gaining market share2025 Growth vs Value & Safe Entry Trade Signal Reports - baoquankhu1.vn
Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026 - Bitget
Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February ... - Caledonian Record
Analysts Confirm Bullish Outlook on Wave Life (WVE) Over Obesity Treatment - Finviz
4.16%
0.71%
자본화:
|
볼륨(24시간):